Maykon Tavares de Oliveira, João Santana da Silva, Marta de Lana, Aroa Silgado, Maria Cláudia Moreira da Silva, J. Antonio Marin-Neto, Israel Molina, Elena Sulleiro, Institut Català de la Salut, [de Oliveira MT] Servei de Malalties infeccioses, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. PROSICS Barcelona, Spain. Cardiology Division, Department of Internal Medicine, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil. [Sulleiro E, Silgado A] Servei de Microbiologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. PROSICS, Barcelona, Spain. [da Silva MC] Department of Biochemistry and Immunology, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil. [de Lana M] Pharmacy School and Center of Research in Biological Sciences, Federal University of Ouro Preto, Ouro Preto, Brazil. [da Silva JS] Fiocruz-Bi-Institutional Translational Medicine Plataform, Ribeirão Preto, Brazil. [Molina I] Servei de Malalties infeccioses, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Marin-Neto JA] Cardiology Division, Department of Internal Medicine, Medical School of Ribeirão Preto, University of São Paulo, São Paulo, Brazil, and Vall d'Hebron Barcelona Hospital Campus
Malaltia de Chagas; Trypanosoma cruzi; Variabilitat genètica Chagas disease; Trypanosoma cruzi; Genetic variability Enfermedad de Chagas; Trypanosoma cruzi; Variabilidad genética Background: Trypanosoma cruzi has a high rate of biological and genetic variability, and its population structure is divided into seven distinct genetic groups (TcI-TcVI and Tcbat). Due to immigration, Chagas disease (ChD), caused by T. cruzi, has become a serious global health problem including in Europe. Therefore, the aim of this study was to evaluate the existence of genetic variability within discrete typing unit (DTU) TcV of T. cruzi in Bolivian patients with chronic ChD residing in Barcelona, Spain. Methods: The DNA was extracted from the peripheral blood of 27 patients infected with T. cruzi DTU TcV and the fragments of the genetic material were amplificated through the low stringency single primer-polymerase chain reaction (LSSP-PCR). The data generated after amplification were submitted to bioinformatics analysis. Results: Of the 27 patients evaluated in the study, 8/27 (29.6%) were male and 19/27 (70.4%) female, 17/27 (62.9%) were previously classified with the indeterminate clinical form of Chagas disease and 10/27 (37.1%) with Chagas cardiomyopathy. The LSSP-PCR detected 432 band fragments from 80 to 1,500 bp. The unweighted pair-group method analysis and principal coordinated analysis data demonstrated the existence of three distinct genetic groups with moderate-high rates of intraspecific genetic variability/diversity that had shared parasite's alleles in patients with the indeterminate and cardiomyopathy forms of ChD. Conclusions: This study demonstrated the existence of a moderate to high rate of intra-DTU TcV variability in T. cruzi. Certain alleles of the parasite were associated with the absence of clinical manifestations in patients harboring the indeterminate form of ChD. These results support the need to search for increasingly specific targets in the genome of T. cruzi to be correlated with its main biological properties and clinical features in patients with chronic ChD. This work was supported by São Paulo Research Foundation (FAPESP)- fapesp.br/en (Grant No. 2018/22093-4), São Paulo Research Foundation (FAPESP)- fapesp.br/en (Grant No. 2019/11943-0), São Paulo Research Foundation (FAPESP)- fapesp.br/en (Grant No. 2016/25403-9), and Universitat Autònoma de Barcelona, Vall d'Hebron University Hospital, PROSICS Barcelona, Spain.